Glucagon-Like Peptide 1: An Introduction and Possible Implications for Neuropsychiatry

J Neuropsychiatry Clin Neurosci. 2024 Spring;36(2):A4-86. doi: 10.1176/appi.neuropsych.20230226.

¹ Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC) and Research and Academic Affairs Service Line, W.G. Hefner Veterans Affairs Medical Center, Salisbury, N.C. (López-Ojeda, Hurley); Department of Psychiatry and Behavioral Medicine (López-Ojeda, Hurley) and Department of Radiology (Hurley), Wake Forest University School of Medicine, Winston-Salem, N.C.; Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston (Hurley).

No abstract available

Keywords: Anxiety; Depression; Glucagon-Like Peptide 1; Glucagon-Like Peptide 1 Receptor Agonist; Homeostasis; Substance Use Disorder.

Publication types